Key Takeaways
- • The Private Equity Stakeholder Project (PESP) released the first-ever national PACE Investment Tracker, documenting rapid private equity expansion into the Program of All-Inclusive Care for the Elderly—a Medicare and Medicaid-funded integrated care model serving approximately 90% dually eligible beneficiaries aged 55+.
- • PACE demonstrates measurable clinical and economic benefits including fewer hospital visits, shorter hospital stays, increased quality of life, and lower overall costs, making it an increasingly attractive investment target for PE firms seeking healthcare sector exposure.
- • Geographic access remains a critical barrier to PACE adoption: as of 2025, 17 states have no PACE programs, and no state offers full statewide access, creating regional disparities that may correlate with investor interest patterns documented in the new tracker.
- • Research indicates for-profit PACE program enrollees experience higher emergency department utilization, greater ED visit frequency, and higher disenrollment rates compared to nonprofit counterparts, raising quality-of-care concerns amid PE investment acceleration.
- • The tracker integrates CMS database enrollment data with investor activity metrics, providing institutional investors and policymakers the first comprehensive tool to monitor PE involvement in a critical Medicare/Medicaid care delivery segment serving high-acuity elderly populations.
Summary
The Private Equity Stakeholder Project released its PACE Investment Tracker in September 2025, marking the first comprehensive national documentation of private equity capital flows into the Program of All-Inclusive Care for the Elderly. PACE is a federally and state-administered program delivering integrated medical and social services to community-dwelling seniors aged 55 and older who qualify for nursing home-level care. With approximately 90% of PACE recipients dually eligible for both Medicare and Medicaid, the program represents a substantial and growing segment of publicly funded elder care delivery.
The tracker's emergence reflects accelerating private equity interest in PACE organizations. The program has demonstrated strong clinical outcomes linked to fewer hospital admissions, shorter inpatient stays, improved quality of life for participants, and reduced caregiver burden—factors that have elevated PACE's profile as an attractive investment opportunity within the healthcare sector. Average PACE recipients are 76 years old with multiple complex medical conditions and significant long-term care needs, making them a high-utilization, high-reimbursement cohort under Medicare and Medicaid fee structures.
However, quality concerns have surfaced alongside PE expansion. Research indicates that for-profit PACE program enrollees experience higher emergency department utilization rates, more frequent ED visits, and greater disenrollment compared to enrollees in nonprofit programs. These outcome disparities raise material questions about care delivery and retention as financial incentives shift toward investor returns.
Geographic fragmentation complicates the investment landscape. As of 2025, 17 states operate no PACE programs whatsoever, and no state has achieved full statewide coverage. This patchwork creates regional access gaps and likely influences PE deployment strategies. The tracker incorporates CMS enrollment databases alongside investor activity metrics, providing institutional investors and policymakers unprecedented visibility into PE involvement patterns across the PACE sector—a critical infrastructure for assessing both financial opportunities and systemic healthcare policy implications.
The tracker's emergence reflects accelerating private equity interest in PACE organizations. The program has demonstrated strong clinical outcomes linked to fewer hospital admissions, shorter inpatient stays, improved quality of life for participants, and reduced caregiver burden—factors that have elevated PACE's profile as an attractive investment opportunity within the healthcare sector. Average PACE recipients are 76 years old with multiple complex medical conditions and significant long-term care needs, making them a high-utilization, high-reimbursement cohort under Medicare and Medicaid fee structures.
However, quality concerns have surfaced alongside PE expansion. Research indicates that for-profit PACE program enrollees experience higher emergency department utilization rates, more frequent ED visits, and greater disenrollment compared to enrollees in nonprofit programs. These outcome disparities raise material questions about care delivery and retention as financial incentives shift toward investor returns.
Geographic fragmentation complicates the investment landscape. As of 2025, 17 states operate no PACE programs whatsoever, and no state has achieved full statewide coverage. This patchwork creates regional access gaps and likely influences PE deployment strategies. The tracker incorporates CMS enrollment databases alongside investor activity metrics, providing institutional investors and policymakers unprecedented visibility into PE involvement patterns across the PACE sector—a critical infrastructure for assessing both financial opportunities and systemic healthcare policy implications.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.